Gary if you understand the investor presentation than you should understand what the company is still continuing to pursue. The 10 mentioned drug development will take years but we also know that the cosmetic route is not full drug development and any development without an indication label is an otc/cosmetic and certainly the big prize for the company and shareholders. During the Wall St.conference the Dr. mentioned the two pronged approach is the plan and have no reason to think otherwise at this point. Please do not get too caught up with what the bashers are saying over there because they obviously have different motives than you and I.